Correspondence | Published:

ACG Clinical Guideline on Crohn’s Disease: A Point of View from Europe

The American Journal of Gastroenterology (2018) | Download Citation

Subjects

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG clinical guideline: management of crohn’s disease in adults. Am J Gastroenterol. 2018;113:481–517.

  2. 2.

    Bhatnagar G, Stempel CVon, Halligan S, et al. Utility of MR enterography and ultrasound for the investigation of small bowel Crohn’s disease. J Magn Reson Imaging. 2017;45:1573–88.

  3. 3.

    Ribaldone DG, Fagoonee S, Astegiano M, et al. Coxib’s safety in patients with inflammatory bowel diseases: a meta-analysis. Pain Physician. 2015;18:599–607.

  4. 4.

    Jørgensen KK, Olsen IC, Goll GL, et al. Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial. Lancet. 2017;389:2304–16.

  5. 5.

    Ribaldone DG, Saracco GM, Astegiano M, et al. Efficacy of infliximab biosimilars in patients with Crohn’s disease. Lancet. 2017;390:2435–2436.

Download references

Author information

Affiliations

  1. Division of Gastroenterology, Department of Medical Sciences, Molinette Hospital, University of Turin, Turin, Italy

    • Davide Giuseppe Ribaldone MD

Authors

  1. Search for Davide Giuseppe Ribaldone MD in:

Guarantor of the article

Davide Giuseppe Ribaldone, MD.

Specific author contributions

The article was conceived and written by Davide Giuseppe Ribaldone.

Financial support

None.

Potential competing interests

None.

Corresponding author

Correspondence to Davide Giuseppe Ribaldone MD.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/s41395-018-0410-3